litany of issues facing the sector over the next few years). This translates to a DCF value of $64. Risks to Rating and Price Target Risks to our Ovenveight rating and price target include I) another leg down in cholesterol sales, 2) failure to effectively manage the core Januvia/vaccines portfolio, and